Renaissance Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
Claim your profile
Overview
Estimated Revenue & Financials
- Renaissance Pharmaceuticals's estimated annual revenue is currently $22.1M per year.
- Renaissance Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Renaissance Pharmaceuticals has 110 Employees.
- Renaissance Pharmaceuticals grew their employee count by 24% last year.
- Renaissance Pharmaceuticals currently has 1 job openings.
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
N/A | 686 | N/A | N/A | - | N/A | |
$372.5M | 1853 | N/A | N/A | - | N/A | |
N/A | 36 | N/A | N/A | - | N/A | |
$22.1M | 110 | 24% | N/A | - | N/A | |
$13.5M | 67 | N/A | N/A | - | N/A | |
$43.4M | 216 | N/A | N/A | - | N/A | |
$15.1M | 75 | 10% | N/A | - | N/A | |
$47.4M | 236 | 15% | N/A | 4.2/5 | N/A | |
$5.6M | 28 | N/A | N/A | - | N/A | |
$14.5M | 72 | N/A | N/A | - | N/A |
Missing a competitor? Contribute!?
Submit
What Is Renaissance Pharmaceuticals?
110
Number of Employees
$22.1M
Revenue (est)
1
Current Jobs
24%
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
N/A
Type
Renaissance Pharmaceuticals News
09/03/2019 - Migraine biotech Satsuma Pharmaceuticals sets terms for $75 ...
Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...
08/16/2019 - Satsuma Pharmaceuticals, a biotech targeting migraines, files ...
Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...
09/03/2019 - Digging Up the Details on Pieris Pharmaceuticals, Inc. (PIRS)
On Friday, shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) marked ... In the meanwhile, Renaissance Technologies LLC also increased ...